Answers are grounded in this paper and cite their sources.
Consensus-based review reports supportive and topical strategies for stem cell transplant recipients with chronic graft-versus-host disease, highlighting targeted management across organ systems.
This is a consensus-based Canadian review with the primary purpose of expanding knowledge regarding supportive and topical therapies for chronic graft vs. host disease (cGvHD). There is often a lack of confidence in treating certain organ specific manifestations, and access to specialists with organ specific expertise varies across the country. This paper covers information gained from a literature review and Canadian transplanter expertise and will serve as a guide for hematopoietic cell transplant healthcare providers to topical cGvHD therapies accessible in Canada. We will review common symptoms and signs focused specifically on skin, mouth, eye and genital tract cGvHD and on lifestyle modifications and topical treatments as an adjunct to our recent publication on systemic treatment for cGvHD.
No takes yet. Share an insight, caveat, or question.
Lepic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: